Shoulai Gu

Papers

Total Citations

H-Index

About

Shoulai Gu is a pioneering researcher at the intersection of artificial intelligence, drug discovery, and aging biology. His work focuses on leveraging AI-driven platforms to identify novel therapeutic targets for age-related diseases, with a particular emphasis on cellular senescence—a key hallmark of aging. Gu’s most notable contribution is the 2024 study "AI-Driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic Agent," which has already garnered 11 citations in a short time. This groundbreaking research demonstrates how machine learning and automated experimentation can rapidly pinpoint compounds that selectively eliminate senescent cells, offering a dual-purpose strategy for treating both aging and chronic diseases. By integrating robotics with computational biology, Gu has pioneered a high-throughput approach that accelerates the discovery of senomorphic agents, potentially transforming how we develop longevity therapeutics. His work represents a significant step toward translating AI-driven discoveries into clinical interventions, positioning him as a rising leader in the field of geroscience and precision medicine.